Literature DB >> 31907722

Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.

Oliver Peacock1, Peadar S Waters2, Joseph C Kong2, Satish K Warrier2, Chris Wakeman3, Tim Eglinton3, Declan G Murphy4, Alexander G Heriot2, Frank A Frizelle3, Jacob J McCormick2.   

Abstract

BACKGROUND: Extensive multi-visceral resection, including components of the urinary tract, is often required to achieve clear resection margins, which is now well established as a key predictor of long-term survival for locally advanced pelvic tumours. The aims of this study were to analyse major morbidity and factors predicting complications and long-term outcomes following a urological procedure within extended radical resections.
METHODS: Data were collected from prospective databases at two high-volume institutions specialising in extended radical resections for locally advanced and recurrent pelvic malignancies between 1990 and 2015. The primary endpoints were general major complications (Clavien-Dindo ≥ 3) and factors influencing complications and overall survival after urological resection.
RESULTS: A total of 646 consecutive patients requiring an extended radical resection for locally advanced or recurrent pelvic malignancies were identified. The median age was 63 years (range 19-89 years) and the majority were female (371; 57.4%). A urological resection was performed as part of the resection in 226 patients (35.0%). The overall 30-day major complication rate was significantly higher in the urological intervention group (23%; n = 52) compared to the non-urological group (12.9%; n = 54 patients; p = 0.001). Intestinal anastomotic leak (p = 0.001) and intra-abdominal collections (p = 0.001) were more common in the urological cohort. Ileal conduit formation was an independent predictor of major morbidity (OR 1.95; 95% CI 1.24-3.07; p = 0.004). Independent prognostic markers for poor 5-year survival following urological procedures were recurrent tumour, cardiovascular disease, previous thromboembolic event and postoperative pulmonary embolism.
CONCLUSIONS: Extended radical resections which include a urological resection are associated with significantly more major morbidity than those without urological resection. Ileal conduit formation is independently associated with the development of major morbidity. Five-year overall survival is no different for patients who had or did not have urological resection as part of extended radical surgery for locally advanced or recurrent pelvic malignancy.

Entities:  

Keywords:  Local recurrence; Morbidity; Neoplasm recurrence; Pelvic exenteration; Pelvic neoplasms; Postoperative complications; Survival; Urinary diversion; Urinary tract

Year:  2020        PMID: 31907722     DOI: 10.1007/s10151-019-02141-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  37 in total

1.  Bricker versus Wallace anastomosis: A meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion.

Authors:  Niall F Davis; John P Burke; Ted McDermott; Robert Flynn; Rustom P Manecksha; John A Thornhill
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Urinary diversion after total pelvic exenteration for rectal cancer.

Authors:  P Russo; B Ravindran; J Katz; P Paty; J Guillem; A M Cohen
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

3.  Colorectal preOperative Surgical Score (CrOSS) for mortality in major colorectal surgery.

Authors:  Cherng Huei Kong; Glenn D Guest; Douglas A Stupart; Ian G Faragher; Steven T F Chan; David A Watters
Journal:  ANZ J Surg       Date:  2015-03-30       Impact factor: 1.872

4.  Survival after pelvic exenteration for T4 rectal cancer.

Authors:  M Kusters; K K S Austin; M J Solomon; P J Lee; G A P Nieuwenhuijzen; H J T Rutten
Journal:  Br J Surg       Date:  2015-01       Impact factor: 6.939

5.  Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.

Authors:  O Peacock; P S Waters; M Bressel; A C Lynch; C Wakeman; T Eglinton; C E Koh; P J Lee; K K Austin; S K Warrier; M J Solomon; F A Frizelle; A G Heriot
Journal:  Br J Surg       Date:  2019-07-24       Impact factor: 6.939

6.  Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer.

Authors:  A Bhangu; S M Ali; A Darzi; G Brown; P Tekkis
Journal:  Colorectal Dis       Date:  2012-12       Impact factor: 3.788

7.  Age and cancer risk: a potentially modifiable relationship.

Authors:  Mary C White; Dawn M Holman; Jennifer E Boehm; Lucy A Peipins; Melissa Grossman; S Jane Henley
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

8.  Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration.

Authors:  K G M Brown; C E Koh; A Vasilaras; D Eisinger; M J Solomon
Journal:  Eur J Surg Oncol       Date:  2013-10-18       Impact factor: 4.424

9.  Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer.

Authors:  Björn Bolmstrand; Per J Nilsson; Torbjörn Holm; Christian Buchli; Gabriella Palmer
Journal:  Eur J Surg Oncol       Date:  2018-07-02       Impact factor: 4.424

10.  Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials.

Authors:  Toru Aoyama; Koji Oba; Michitaka Honda; Sotaro Sadahiro; Chikuma Hamada; Shuhei Mayanagi; Mitsuro Kanda; Hiromichi Maeda; Kosuke Kashiwabara; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa
Journal:  Cancer Med       Date:  2017-06-22       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.